학술논문
902P Quality of life and response to treatment with ixazomib-lenalidomide-dexamethasone (IRd) in patients with relapsed/refractory multiple myeloma (RRMM) in a real-world setting
Document Type
Abstract
Author
Source
In Annals of Oncology September 2020 31 Supplement 4:S655-S655
Subject
Language
ISSN
0923-7534